Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

DISEASE CHARACTERISTICS: * Histologically or cytologically confirmed fallopian tube cancer, Muellerian mixed tumor, endometrial cancer, uterine sarcoma, ovarian cancer with sarcoma parts, or cervical cancer * No ovarian epithelial cancer PATIENT CHARACTERISTICS: Age: * 18 and over Performance status: * ECOG 0-2 OR * Karnofsky 70-100% Life expectancy: * At least 3 months Hematopoietic: * Absolute neutrophil count at least 1,500/mm3 * Platelet count at least 100,000/mm3 * Hemoglobin greater than 10.0 g/dL Hepatic: * Bilirubin no greater than 1.25 times upper limit of normal Renal: * Glomerular filtration rate at least 60 mL/min Cardiovascular: * No atrial or ventricular arrhythmias * No congestive heart failure even if stabilized on medication * No New York Heart Association class III or IV heart disease * No myocardial infarction within the past 6 months Other: * No pre-existing sensory or motor neuropathy grade 2 or greater * No active infection * No other serious medical condition that would preclude study * Not pregnant * Negative pregnancy test * Fertile patients must use effective contraception PRIOR CONCURRENT THERAPY: Biologic therapy: * At least 4 weeks since prior immunotherapy Chemotherapy: * No more than 1 prior chemotherapy regimen for the malignancy * No other concurrent chemotherapy Endocrine therapy: * Prior hormonal therapy within the past 10 days allowed * No concurrent hormonal therapy Radiotherapy: * At least 6 weeks since prior…